Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elias Orouji

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Bioinformatics (Oxford, England)|June 12, 2021
Methylation-eQTL analysis in cancer researchYusha Liu, Keith A Baggerly, Elias Orouji, et al.
Pigment Cell & Melanoma Research|April 1, 2015
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based modelLionel Larribere, Huizi Wu, Daniel Novak, et al.
Leukemia|September 21, 2022
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genomeHéléna Boutzen, Seyed Ali Madani Tonekaboni, Michelle Chan-Seng-Yue, et al.
Nature Communications|March 30, 2023
MYC reshapes CTCF-mediated chromatin architecture in prostate cancerZhao Wei, Song Wang, Yaning Xu, et al.
Leukemia|February 13, 2022
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cellsBoaz Nachmias, Dilshad H Khan, Veronique Voisin, et al.
Cell Stem Cell|May 17, 2020
Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-RenewalRashim Pal Singh, Danny V Jeyaraju, Veronique Voisin, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
Gut|June 1, 2021
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancerElias Orouji, Ayush T Raman, Anand K Singh, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Bioinformatics (Oxford, England)|June 12, 2021
Methylation-eQTL analysis in cancer researchYusha Liu, Keith A Baggerly, Elias Orouji, et al.
Pigment Cell & Melanoma Research|April 1, 2015
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based modelLionel Larribere, Huizi Wu, Daniel Novak, et al.
Leukemia|September 21, 2022
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genomeHéléna Boutzen, Seyed Ali Madani Tonekaboni, Michelle Chan-Seng-Yue, et al.
Nature Communications|March 30, 2023
MYC reshapes CTCF-mediated chromatin architecture in prostate cancerZhao Wei, Song Wang, Yaning Xu, et al.
Leukemia|February 13, 2022
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cellsBoaz Nachmias, Dilshad H Khan, Veronique Voisin, et al.
Cell Stem Cell|May 17, 2020
Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-RenewalRashim Pal Singh, Danny V Jeyaraju, Veronique Voisin, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
Gut|June 1, 2021
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancerElias Orouji, Ayush T Raman, Anand K Singh, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Pageof 3